United States v. Mark Tamarin

CourtCourt of Appeals for the Ninth Circuit
DecidedApril 15, 2021
Docket20-50048
StatusUnpublished

This text of United States v. Mark Tamarin (United States v. Mark Tamarin) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Mark Tamarin, (9th Cir. 2021).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 15 2021 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA, No. 20-50048

Plaintiff-Appellee, D.C. No. 2:17-cr-00344-DSF-1 v.

MARK WILFRED TAMARIN, MEMORANDUM*

Defendant-Appellant.

Appeal from the United States District Court for the Central District of California Dale S. Fischer, District Judge, Presiding

Submitted April 13, 2021** Pasadena, California

Before: M. SMITH and IKUTA, Circuit Judges, and VRATIL,*** District Judge.

Defendant-Appellant Mark Wilfred Tamarin (Tamarin) appeals his 71-month

custodial sentence arising from his conviction on six counts of wire fraud,

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). *** The Honorable Kathryn H. Vratil, United States District Judge for the District of Kansas, sitting by designation. 18 U.S.C. § 1343, and one count of attempted health care fraud, 18 U.S.C. § 1347,

relating to a scheme to defraud Medicare. Because the parties are familiar with the

facts, we do not recount them here, except as necessary to provide context to our

ruling.

We have jurisdiction under 18 U.S.C. § 3742(a) and 28 U.S.C. § 1291. We

review the district court’s interpretation of the Guidelines issued by the United

Sentencing Commission (Guidelines) de novo, application of the Guidelines to the

facts for abuse of discretion, and factual findings for clear error. United States v.

Staten, 466 F.3d 708, 713 (9th Cir. 2006). We affirm.

1. Tamarin argues that the district court erred by applying a 14-level

enhancement for loss because the intended loss amount found by the district court

was not supported by clear and convincing evidence. Specifically, Tamarin argues

that the loss attributable to the fraudulent post-void residuals (PVRs) and renal

ultrasounds was based on “speculation and conjecture” and that the intended loss

should be reduced to the amounts actually paid by Medicare rather than the amounts

billed to Medicare.

The Guidelines define intended loss as “the pecuniary harm that the defendant

purposely sought to inflict.” U.S.S.G. § 2B1.1(b)(1), comment. n.3(A)(ii). The

Guidelines provide that the “court need only make a reasonable estimate of the loss,”

a determination that “is entitled to appropriate deference.” U.S.S.G. § 2B1.1(b)(1),

2 comment. n.3(C); see also United States v. Garro, 517 F.3d 1163, 1167 (9th Cir.

2008).

With respect to the evidence presented at trial, Advanced Urology Medical

Office (AUMO) employees testified that Tamarin ordered more PVRs and renal

ultrasounds than any other doctor in the practice, even ordering them without seeing

the patient and announcing that a particular day was “PVR day.” In addition,

summary charts introduced at trial corroborated this testimony, demonstrating that

Tamarin ordered significantly more PVRs and renal ultrasounds than his partners.

To calculate the loss amount, the district court agreed with the government’s

method that compared Tamarin’s PVR and renal ultrasound billing to that of his

partner at AUMO who billed the next highest amount for these tests, the difference

being the fraudulent amount. This calculation was reasonable because all four

AUMO partners saw a similar patient population, and the partner with whom

Tamarin’s billing was compared, actually saw more patients in the office than

Tamarin did.

Tamarin argues that the calculation was improper because it did not consider

potential differences between Tamarin’s medical practice and other physicians in his

medical group. Tamarin contends these differences could be the percentage of

Medicare patients seen by each physician as well as the types of insurance accepted.

3 Therefore, Tamarin argues, calculation of the loss amount based on such a

comparison is speculative and based on conjecture.

However, Tamarin offered no evidence showing any differences that would

justify the amount he billed—which was double-to-triple the amount of his

colleagues. While Tamarin speculates that there “could be” differences in Medicare

patients, this does not suggest the district court’s inclusion of the loss stemming from

the fraudulent PVRs and renal ultrasounds was illogical, implausible, or without

support in the record. See United States v. Hinkson, 585 F.3d 1247, 1262 (9th Cir.

2009) (en banc). Therefore, the district court did not clearly err by concluding the

government’s method of calculating loss was reasonable.

With respect to Tamarin’s argument that the intended loss should be reduced

to the amounts paid by Medicare rather than the amounts billed to Medicare,

Tamarin relies on United States v. Popov, 742 F.3d 911 (9th Cir. 2014) and

United States v. Moran, 778 F.3d 942 (11th Cir. 2015). This argument fails for two

reasons.

First, the Guidelines provide that “the aggregate dollar amount of fraudulent

bills submitted to the Government health care program shall constitute prima facie

evidence of the amount of intended loss.” U.S.S.G. § 2B1.1, comment. n.3(F)(viii).

Here, the district court found that the government proved by clear and convincing

4 evidence that the billed amount was $723,655.99, which provides prima facie

evidence exceeding the $550,000 threshold for the 14-level enhancement.

Second, unlike the defendants in Popov and Moran, Tamarin introduced no

evidence supporting his claim that he intended to be paid less than the amounts billed

to Medicare. Importantly, Tamarin offered no documents or testimony regarding his

understanding as to Medicare reimbursement amounts. Instead, Tamarin’s attorney

argued that “because of his many years of experience dealing with Medicare billing,

[Tamarin] was aware that Medicare did not pay the amount billed for medical

services.” These attorney arguments without supporting evidence are insufficient to

rebut the prima facie showing. Therefore, the district court did not err when it agreed

with the government and Probation Office and overruled Tamarin’s objections to the

loss calculations.

Accordingly, the district court did not clearly err in applying a 14-level

enhancement for loss because the intended loss amount found by the district court

was supported by clear and convincing evidence in the record.

2. Tamarin next argues that the district court erred by applying a two-level

enhancement for obstruction of justice.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Ellis
641 F.3d 411 (Ninth Circuit, 2011)
United States v. Ressam
679 F.3d 1069 (Ninth Circuit, 2012)
United States v. Hinkson
585 F.3d 1247 (Ninth Circuit, 2009)
United States v. Carty
520 F.3d 984 (Ninth Circuit, 2008)
United States v. Garro
517 F.3d 1163 (Ninth Circuit, 2008)
United States v. Indalecio Castro-Ponce
770 F.3d 819 (Ninth Circuit, 2014)
United States v. Anthony Roberts
778 F.3d 942 (Eleventh Circuit, 2015)
United States v. Staten
466 F.3d 708 (Ninth Circuit, 2006)
United States v. Alexander Popov
742 F.3d 911 (Ninth Circuit, 2014)
United States v. Terry Christensen
828 F.3d 763 (Ninth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Mark Tamarin, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-mark-tamarin-ca9-2021.